Instant Access Registration Takes Less Than 15 Seconds! You May Not Post Until Registered.
To start viewing messages, select the forum that you want to visit from the selection below.
If you are having trouble staying logged in when navigating between forums/topics/etc., you need to reset your session cookie. Go into your browser and delete any cookie for the site them log back in. This should fix the login issue.
Ok...who here has used anavar before? I would like to know some personal experiences upon usage, as in what MG did you take it at, for how long, also if you stacked it with something else(what) and RESULTS please?
I've used Anavar alone (BTG 30 mg ED). My best cycle so far. No sides, BP remained the same, gained 8 lbs. Now I'm about to do a 3 week cycle of cyp and anavar.
if i had the money id go for an anavar only cycle.
all my buddies that have done a var cycle seemed to enjoy the results, although not many saw a weight increase like MANNY, they did see their strenght go up faily well
right now all i got is winny, which im not complaining but if i can get some money before my winny runs out (ill be starting mid feb. ending 6 weeks later) ill think about some anavar (but 90% likely i can't afford var)
Originally posted by iamcdn if i had the money id go for an anavar only cycle.
all my buddies that have done a var cycle seemed to enjoy the results, although not many saw a weight increase like MANNY, they did see their strenght go up faily well
right now all i got is winny, which im not complaining but if i can get some money before my winny runs out (ill be starting mid feb. ending 6 weeks later) ill think about some anavar (but 90% likely i can't afford var)
the key with anavar is protein intake. Usually I won't follow the 2g per lbs rule, except with anavar. 75% of my diet will be made of Tuna, chicken and protein shakes.
Here's something I read at Bolex, kkrammer posted it. I don't know how old you are, but this might help.
Anavar seems to be great for fat loss, but is not exactly something i would call "safe":
Int J Obes Relat Metab Disord 1995 Sep;19(9):614-24
Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men.
Lovejoy JC, Bray GA, Greeson CS, Klemperer M, Morris J, Partington C, Tulley R.
Pennington Biomedical Research Center, Baton Rouge, Louisiana 70808-4124, USA.
OBJECTIVE: To compare the effects of testosterone enanthate (TE), anabolic steroid (AS) or placebo (PL) on regional fat distribution and health risk factors in obese middle-aged men undergoing weight loss by dietary means. DESIGN: Randomized, double-blind, placebo-controlled clinical trial, carried out for 9 months with primary assessments at 3 month intervals. Due to adverse blood lipid changes, the AS group was switched from oral oxandrolone (ASOX) to parenteral nandrolone decaoate (ASND) after the 3 month assessment point. SUBJECTS: Thirty healthy, obese men, aged 40-60 years, with serum testosterone (T) levels in the low-normal range (2-5 ng/mL). MAIN OUTCOME MEASURES: Abdominal fat distribution and thigh muscle volume by CT scan, body composition by dual energy X-ray absorptiometry (DEXA), insulin sensitivity by the Minimal Model method, blood lipids, blood chemistry, blood pressure, thyroid hormones and urological parameters. RESULTS: After 3 months, there was a significantly greater decrease in subcutaneous (SQ) abdominal fat in the ASOX group compared to the TE and PL groups although body weight changes did not differ by treatment group. There was also a tendency for the ASOX group to exhibit greater losses in visceral fat, and the absolute level of visceral fat in this group was significantly lower at 3 months than in the TE and PL groups. There were significant main effects of treatment at 3 months on serum T and free T (increased in the TE group and decreased in the ASOX group) and on thyroid hormone parameters (T4 and T3 resin uptake significantly decreased in the ASOX group compared with the other two groups). There was a significant decrease in HDL-C, and increase in LDL-C in the ASOX group, which led to their being switched to the parenteral nandrolone decanoate (ASND) after 3 months. ASND had opposite effects on visceral fat from ASOX, producing a significant increase from 3 to 9 months while continuing to decrease SQ abdominal fat. ASND treatment also decreased thigh muscle area, while ASOX treatment increased high muscle. ASND reversed the effects of ASOX on lipoproteins and thyroid hormones. The previously reported effect of T to decrease visceral fat was not observed, in fact, visceral fat in the TE group increased slightly from 3 to 9 months, although SQ fat continued to decrease. Neither TE nor AS treatment resulted in any change in urologic parameters. CONCLUSIONS: Oral oxandrolone decreased SQ abdominal fat more than TE or weight loss alone and also tended to produce favorable changes in visceral fat. TE and ASND injections given every 2 weeks had similar effects to weight loss alone on regional body fat. Most of the beneficial effects observed on metabolic and cardiovascular risk factors were due to weight loss per se. These results suggest that SQ and visceral abdominal fat can be independently modulated by androgens and that at least some anabolic steroids are capable of influencing abdominal fat.
We process personal data about users of our site, through the use of cookies and other technologies, to deliver our services, personalize advertising, and to analyze site activity. We may share certain information about our users with our advertising and analytics partners. For additional details, refer to our Privacy Policy.
By clicking "I AGREE" below, you agree to our Privacy Policy and our personal data processing and cookie practices as described therein. You also acknowledge that this forum may be hosted outside your country and you consent to the collection, storage, and processing of your data in the country where this forum is hosted.
Comment